RIPK1 and diabetic kidney disease: Animal studies have shown that the administration of a RIPK1 inhibitor effectively suppresses the activation of necroptosis in the renal tissues of DKD mice fed a HFD, reduces necroinflammation in the kidneys, and protects renal tissue (Yu et al. 2023).